News & Events

A research paper by general surgery resident Emily Huang, M.D. (pictured right), entitled "From Novice to Master Surgeon: Improving Feedback with a Descriptive Approach to Intraoperative Assessment," was chosen by the Association for Surgical Education (ASE) Program Committee as a Paper of Distinction. The paper...

Frontline Medical News reports on the expanded roles and responsibilities nurse practitioners are assuming in the provision of critical care services in an interview with Thomas Farley, RN, NP, ACNP-BC, c o-Director, of the Surgical and Critical Care NP Fellowship Program at UCSF: At the University of California...

UCSF News report on a joint collaboration between UCSF and Walgreen that provides blood pressure testing at no charge to living kidney donors. While recipients of living donor kidney transplants receive steady follow-up care, the living donors themselves also need to be monitored. To make follow-up care more...

In another demonstration of the Department of Surgery 's commitment to global health and outreach, UCSF transplant surgeon Andrew M. Posselt, M.D., Ph.D. , recently travelled to Cali, Colombia to help lay the groundwork for a laparoscopic donor nephrectomy program at the Fundacion Clinica Valle del Lili, a leading...

The UCSF Transplant Program will have a strong presence at the World Transplant Congress (WTC), to be held July 26–31, 2014 at Moscone West Convention Center in San Francisco. The WTC brings together the members of the American Society of Transplant Surgeons (ASTS), The Transplantation Society (TTS) and the...

General surgery residents Bian Wu, M.D. (left), Evan Werlin, M.D. (center) and Victoria Lyo, M.D. (right), coached by Matthew Y.C. Lin, M.D., Assistant Professor Surgery, Division of General Surgery, were winners of the the first laparoscopic competition held at the Northern California Chapter of the American...

UCSF's Kidney Transplant Program has ranked number one in the country for transplant volume, according to the newest data just released by the Scientific Registry of Transplant Recipients (SRTR). The program, led by John Roberts, M.D., Chief of the Transplant Service and Division of Transplant Surgery at UCSF...

UCSF News reports on new results showing the promise and potential of I-SPY 2 Trial, personalized medicine study designed to identify breast cancer patients most likely to benefit from an array experimental drugs. In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with...

"Researchers studying the effects of immune suppressant drugs on transplant patients with HIV have made a surprising discovery: A drug intended to hobble the body's defense system may actually help destroy dormant reservoirs of the virus that causes AIDS In a paper published this week in the American Journal of...

"The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UC San Francisco researchers have found in a new study. The findings, published online March 16 in Nature Medicine , may lead...

A clinical study led by UCSF Vascular Surgeon Marlene Grenon, M.D., C.M. looked at the effects of physical inactivity on vascular endothelial function and arterial stiffness, two measures that relate to cardiovascular risk. The results showed that a short term exposure to physical inactivity leads to quantifiable...

UCSF News reports on the work of Qizhi Tang, Ph.D., and other UC San Francisco researchers to develop new organ transplant strategies that better prevent rejection of donated organs. The research of Dr. Tang, Associate Professor in the Division of Transplant Surgery, and Director of the Transplantation Research...

A recent paper in the journal Nature, reported by UCSF News by a research team including Associate Professor Holger Willenbring, M.D., Ph.D. and Senior Resident Jack Harbell, M.D., a former postdoctoral fellow in the Willenbring lab, reports a new method of cellular reprogramming with potential for treating liver...

Advances in the treatment of complex aortic aneurysms — especially novel endovascular devices and hybrid procedures — make it possible to choose the right procedure for the right patient at the right time to minimize risk and maximize long-term benefit, says Michael Conte, M.D. , chief of the Division of Vascular...

UCSF News report on how the immune system drives pregnancy complications after fetal surgery in mice. As a fetal surgeon at UC San Francisco, Tippi MacKenzie, MD, has long known that conducting surgery on a fetus to correct a problems such as spina bifida often results in preterm labor and premature birth. Now...